These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4096874)

  • 61. Deferoxamine (DFO): the effectiveness for noninvasive diagnosis of aluminum-related bone disease, and for treatment of the disease.
    Marumo F; Umetani N; Sato N; Takahashi Y
    J UOEH; 1987 Mar; 9 Suppl():140-52. PubMed ID: 3602745
    [No Abstract]   [Full Text] [Related]  

  • 62. [A study of bone metabolism in hemodialysis patients. I. Correlation with bone histology and serum levels of PTH, vitamin D metabolites, and vitamin A].
    Ohara K
    Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):417-36. PubMed ID: 3230693
    [No Abstract]   [Full Text] [Related]  

  • 63. Uremic toxin and bone metabolism.
    Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
    J Bone Miner Metab; 2006; 24(2):172-5. PubMed ID: 16502128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia.
    Quarles LD; Lobaugh B; Murphy G
    J Clin Endocrinol Metab; 1992 Jul; 75(1):145-50. PubMed ID: 1619003
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis.
    Ritz E; Krempien B; Mehls O; Malluche H
    Kidney Int; 1973 Aug; 4(2):116-27. PubMed ID: 4790866
    [No Abstract]   [Full Text] [Related]  

  • 66. Hypercalcaemic osteomalacia due to aluminium toxicity.
    Boyce BF; Fell GS; Elder HY; Junor BJ; Elliot HL; Beastall G; Fogelman I; Boyle IT
    Lancet; 1982 Nov; 2(8306):1009-13. PubMed ID: 6127501
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Renal osteodystrophy in children on maintenance haemodialysis.
    Mehls O; Krempien B; Ritz E; Schärer K; Schüler HW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):197-201. PubMed ID: 4802577
    [No Abstract]   [Full Text] [Related]  

  • 68. Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism.
    Hodsman AB; Sherrard DJ; Wong EG; Brickman AS; Lee DB; Alfrey AC; Singer FR; Norman AW; Coburn JW
    Ann Intern Med; 1981 May; 94(5):629-37. PubMed ID: 6894520
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Is aluminum poisoning unavoidable in the uremic patient?].
    Drüeke T; Rottembourg J
    Nephrologie; 1985; 6(5):217-8. PubMed ID: 4094634
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
    Lieuallen WG; Weisbrode SE
    J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
    Felsenfeld AJ
    ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318
    [No Abstract]   [Full Text] [Related]  

  • 73. [Aluminum in human pathology].
    Lewandowska-Szumieł M; Komender J
    Pol Arch Med Wewn; 1988 Mar; 79(3):159-70. PubMed ID: 2980661
    [No Abstract]   [Full Text] [Related]  

  • 74. Aluminium-related osteomalacia: response to reverse osmosis water treatment.
    Smith GD; Winney RJ; McLean A; Robson JS
    Kidney Int; 1987 Jul; 32(1):96-101. PubMed ID: 3626303
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis.
    Felsenfeld AJ; Gutman RA; Llach F; Harrelson JM
    Am J Nephrol; 1982; 2(3):147-54. PubMed ID: 7180912
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aluminum and parathyroid hormone concentrations in insulin-dependent diabetics on long-term hemodialysis.
    Seidl K; Mrzljak V; Pavlović D; Romić Z; Granić M; Rocić B
    Nephron; 1991; 59(3):502-3. PubMed ID: 1758549
    [No Abstract]   [Full Text] [Related]  

  • 77. The evolution of osteomalacia in the rat with acute aluminum toxicity.
    Rodriguez M; Felsenfeld AJ; Llach F
    J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of uraemic metabolites on parathyroid extract-induced bone resorption in vitro.
    Wills MR; Jenkins MV
    Clin Chim Acta; 1976 Nov; 73(1):121-5. PubMed ID: 1000820
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.
    Piraino B; Chen T; Puschett JB
    Am J Nephrol; 1989; 9(3):190-7. PubMed ID: 2757078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.